5/2/2019 | DD | Synergy Pharmaceuticals’ fourth amended reorganization plan effective
|
4/29/2019 | DD | Synergy Pharmaceuticals posts $14.5 million operating loss for March
|
4/25/2019 | DD | Synergy Pharmaceuticals fourth amended reorganization plan confirmed
|
4/16/2019 | DD | Synergy fourth amended plan unanimously accepted by voting creditors
|
4/12/2019 | DD | Synergy: U.S. trustee raises objections to amended Chapter 11 plan
|
4/10/2019 | DD | Synergy Pharmaceuticals plan-changing settlement approved by court
|
3/29/2019 | DD | Synergy Pharmaceuticals settlement calls for Chapter 11 plan changes
|
3/25/2019 | DD | Synergy seeks 60-day extension of exclusive plan periods
|
3/19/2019 | DD | Synergy lender agent seeks contempt ruling after equity group appeals
|
3/13/2019 | DD | Synergy disclosure statement approved; plan hearing set for April 23
|
3/12/2019 | DD | Synergy Pharmaceuticals equityholders group appeals financing order
|
3/5/2019 | DD | Synergy creditors committee and U.S. Trustee object to plan releases
|
3/1/2019 | DD | Synergy Pharmaceuticals’ $200 million asset sale approved by court
|
2/27/2019 | DD | Synergy names Bausch entities as winning bidder for company assets
|
2/26/2019 | DD | Synergy Pharmaceuticals gets final OK of $45 million new-money loan
|
2/25/2019 | DD | Synergy Pharmaceuticals disclosure statement hearing reset to March 12
|
2/22/2019 | DD | Synergy Pharmaceuticals plan release provisions trigger SEC objection
|
1/29/2019 | DD | Synergy Pharmaceuticals committee of equity security holders named
|
1/10/2019 | DD | Synergy, Bausch asset purchase agreement amended to resolve objections
|
1/7/2019 | DD | Synergy Pharmaceuticals gets court approval of asset sale procedures
|
12/31/2018 | DD | Synergy Pharmaceuticals committee objects to asset sale procedures
|
12/24/2018 | DD | Synergy files plan, secures further interim access to DIP financing
|
12/21/2018 | DD | Synergy Pharmaceuticals committee questions financing request timing
|
12/20/2018 | DD | Synergy Pharmaceuticals’ committee of unsecured creditors appointed
|
12/14/2018 | DD | Synergy Pharmaceuticals granted access to $11.5 million in financing
|
12/14/2018 | BKCVDDEMHY | Prospect News reports five new defaults for week of Dec. 6 to Dec. 12
|
12/12/2018 | BKCVDD | Synergy Pharmaceuticals bankrupt, gets $200 million bid for assets
|
6/13/2018 | BKPV | Synergy Pharmaceuticals amends CRG agreement to extend drawdown date
|
9/5/2017 | BKPV | Synergy Pharmaceuticals arranges up to $300 million 9˝% secured loans
|
11/21/2016 | CVLM | Synergy to issue stock in exchange for $20.7 million 7.5% convertibles
|
9/14/2016 | CV | Market Commentary: New, upsized Oasis Petroleum convertibles drop below par; new AMD bonds regain footing
|
5/5/2016 | PP | Synergy to conduct $89.85 million registered direct sale of its stock
|
3/18/2016 | PP | Market Commentary: Energy convertibles extend gains; Whiting outperforms on exchanges; Synergy sags on exchange
|
3/18/2016 | CV | Market Commentary: Energy convertibles extend gains; Whiting outperforms on exchanges; Synergy sags on exchange
|
3/18/2016 | CVLM | Synergy to exchange $79.7 million 7.5% convertibles for common stock
|
9/18/2015 | PP | Market Commentary: Convertibles quiet, steady post Fed; some health-care names better bid; Medicines edges up
|
9/18/2015 | CV | Market Commentary: Convertibles quiet, steady post Fed; some health-care names better bid; Medicines edges up
|
6/19/2015 | CV | Market Commentary: Ctrip.com tranches flat on debut; newer Restoration Hardware lower; Healthways up on swap
|
6/18/2015 | CV | Market Commentary: Discounted Restoration Hardware remains below par; planned Ctrip.com seen modestly cheap
|
6/17/2015 | PP | Market Commentary: Qihoo higher on going-private proposal; Ctrip.com launches $1 billion deal; Synergy spikes
|
6/17/2015 | CV | Market Commentary: Qihoo higher on going-private proposal; Ctrip.com launches $1 billion deal; Synergy spikes
|
6/17/2015 | CV | Market Commentary: Morning Commentary: Restoration Hardware deal quiet in the gray; Synergy spikes on positive data
|
6/11/2015 | PP | Market Commentary: New Proofpoint looks somewhat cheap; existing Proofpoint comes in small; Ironwood lingers
|
6/11/2015 | CV | Market Commentary: New Proofpoint looks somewhat cheap; existing Proofpoint comes in small; Ironwood lingers
|
6/9/2015 | CV | Market Commentary: Planned Ironwood looks cheap; Avid pricing also looks fairly cheap; Micron notes improve
|
5/18/2015 | CV | Market Commentary: Convertibles mostly in line; SanDisk, Yahoo! flat; Interactive Intelligence notes on tap
|
3/26/2015 | PP | Market Commentary: SanDisk expands on swap after revenue view cut; buyers seen in NXP; Synergy exploring sale
|
3/26/2015 | CV | Market Commentary: SanDisk expands on swap after revenue view cut; buyers seen in NXP; Synergy exploring sale
|
3/26/2015 | CV | Market Commentary: Morning Commentary: SanDisk expands on swap after outlook cut; Synergy Pharma exploring a sale
|
3/13/2015 | PP | Market Commentary: FXCM bumps up on positive earnings; Herbalife adds outright, unchanged dollar neutral
|
3/13/2015 | CV | Market Commentary: FXCM bumps up on positive earnings; Herbalife adds outright, unchanged dollar neutral
|
12/31/2014 | CV | Market Commentary: Outlook 2015: U.S. convertibles primary notches multi-year high; volume expected to climb
|
10/30/2014 | CV | Synergy greenshoe lifts 7.5% five-year convertibles to $200 million
|
10/29/2014 | PP | Market Commentary: Convertibles little changed ahead of the Fed; American Realty drops; Synergy prices deal
|
10/29/2014 | CV | Market Commentary: Convertibles little changed ahead of the Fed; American Realty drops; Synergy prices deal
|
10/29/2014 | CV | Market Commentary: Morning Commentary: Synergy prices upsized deal; American Realty falls, cites accounting errors
|
10/29/2014 | CV | New Issue: Synergy Pharmaceuticals sells upsized $175 million five-year convertibles to yield 7.5%
|
10/28/2014 | PP | Market Commentary: Twitter drops outright, mixed to lower on hedge; Medicines opens up; Synergy to price
|
10/28/2014 | CV | Market Commentary: Twitter drops outright, mixed to lower on hedge; Medicines opens up; Synergy to price
|
10/28/2014 | CV | Synergy Pharmaceuticals to price up to $150 million five-year convertible notes to yield 7.5%
|
6/21/2012 | CVHYPF | Synergy Pharmaceuticals files $250 million stock and preferreds shelf
|
6/6/2012 | PP | Synergy wraps remaining greenshoe in $51.75 million public stock sale
|
6/5/2012 | PP | Synergy Pharmaceuticals seals $48.38 million public offering of stock
|
5/4/2012 | PP | Synergy Pharmaceuticals prices $45 million public offering of stock
|
12/1/2011 | PP | Synergy Pharmaceuticals prices $15 million public sale of equity units
|
11/18/2011 | PP | Synergy Pharmaceuticals to price $15 million public offering of units
|
11/15/2011 | PP | Synergy Pharmaceuticals wraps $5.65 million placement of units
|
9/28/2011 | PP | Synergy Pharmaceuticals prices $5 million public units sale at $2.125
|
9/16/2011 | PP | Synergy Pharmaceuticals aims to price public offering of equity units
|
7/19/2011 | PP | Synergy Pharmaceuticals prices $2.63 million public offering of stock
|
7/18/2011 | PP | Synergy Pharmaceuticals aims to price public offering of common stock
|
7/18/2011 | PP | Synergy Pharmaceuticals aims to price public offering of common stock
|
4/28/2011 | PP | Synergy Pharmaceuticals heralds $2.5 million public offering of stock
|
10/19/2010 | PP | Synergy Pharmaceuticals plans $3.13 million direct offering of stock
|
10/1/2010 | PP | Synergy Pharmaceuticals arranges $2.5 million direct stock offering
|
11/24/2009 | CVHY | Synergy Pharmaceuticals files $100 million stock, preferreds shelf
|
11/12/2009 | PP | New Issue: Synergy Pharmaceuticals seals $8.6 million private placement of stock
|
11/12/2009 | PP | Market Commentary: East West seals $500 million; MAP secures credit facility; Novelos closes $9 million financing
|
11/5/2009 | PP | New Issue: Synergy Pharmaceuticals sells $7.35 million shares in private placement
|
7/7/2009 | PP | New Issue: Synergy Pharmaceuticals wraps $7.09 million placement of shares
|
7/2/2009 | PP | New Issue: Synergy Pharmaceuticals seals $5.32 million private placement of shares
|
8/30/2006 | BT | Market Commentary: AnorMED snubs Genzyme bid; PDL higher as Roche backs out; Vasogen zooms 42%; Adeza up
|